A preoperative predictive score of pancreatic fistula following pancreatoduodenectomy

HPB

Volumn 16, Issue 7, 2014, Pages 620-628

  Roberts, Keith J ^a   Hodson, James ^a   Mehrzad, Homoyoon ^a   Marudanayagam, Ravi ^a   Sutcliffe, Robert P ^a   Muiesan, Paolo ^a   Isaac, John ^a   Bramhall, Simon R ^a   Mirza, Darius F ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMPULLARY CARCINOMA; BENIGN TUMOR; BILE DUCT CARCINOMA; BLOOD EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DUODENUM CARCINOMA; FEMALE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROENDOCRINE TUMOR; PANCREAS ADENOCARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; PATIENT COUNSELING; POST HOC ANALYSIS; PREDICTIVE SCORE; PREOPERATIVE EVALUATION; RISK FACTOR; SCORING SYSTEM; AREA UNDER THE CURVE; BLOOD; DECISION SUPPORT SYSTEM; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PANCREATIC FISTULA; PATIENT SELECTION; PREDICTIVE VALUE; PREOPERATIVE CARE; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL MODEL; TREATMENT OUTCOME; VALIDATION STUDY;

BIOLOGICAL MARKER;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBSERVER VARIATION; PANCREATIC FISTULA; PANCREATICODUODENECTOMY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84902544735     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12186     Document Type: Conference Paper

References (46)

1. Balzano G, Zerbi A, Capretti G, Rocchetti S, Capitanio V, Di Carlo V,. (2008) Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg 95: 357-362.
2. de Wilde RF, Besselink MG, van der Tweel I, de Hingh IH, van Eijck CH, Dejong CH, et al. (2012) Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality. Br J Surg 99: 404-410.
3. Schmidt CM, Turrini O, Parikh P, House MG, Zyromski NJ, Nakeeb A, et al. (2010) Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg 145: 634-640.
4. van Heek NT, Kuhlmann KF, Scholten RJ, de Castro SM, Busch OR, van Gulik TM, et al. (2005) Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg 242: 781-788.
5. Aroori S, Puneet P, Bramhall SR, Muiesan P, Mayer AD, Mirza DF, et al. (2011) Outcomes comparing a pancreaticogastrostomy (PG) and a pancreaticojejunostomy (PJ) after a pancreaticoduodenectomy (PD). HPB 13: 723-731.
6. McPhee JT, Hill JS, Whalen GF, Zayaruzny M, Litwin DE, Sullivan ME, et al. (2007) Perioperative mortality for pancreatectomy: a national perspective. Ann Surg 246: 246-253.
7. Winter JM, Cameron JL, Campbell KA, Arnold MA, Chang DC, Coleman J, et al. (2006) 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg 10: 1199-1210.
8. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138: 8-13.
9. Connor S, Alexakis N, Garden OJ, Leandros E, Bramis J, Wigmore SJ,. (2005) Meta-analysis of the value of somatostatin and its analogues in reducing complications associated with pancreatic surgery. Br J Surg 92: 1059-1067.
10. Diener MK, Fitzmaurice C, Schwarzer G, Seiler CM, Antes G, Knaebel HP, et al. (2011) Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev (5) CD006053.
11. Diener MK, Tadjalli-Mehr K, Wente MN, Kieser M, Buchler MW, Seiler CM,. (2011) Risk-benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence. Langenbecks Arch Surg 396: 41-52.
12. Koti RS, Gurusamy KS, Fusai G, Davidson BR,. (2010) Meta-analysis of randomized controlled trials on the effectiveness of somatostatin analogues for pancreatic surgery: a Cochrane review. HPB 12: 155-165.
13. Wente MN, Shrikhande SV, Muller MW, Diener MK, Seiler CM, Friess H, et al. (2007) Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis. Am J Surg 193: 171-183.
14. Gaujoux S, Cortes A, Couvelard A, Noullet S, Clavel L, Rebours V, et al. (2010) Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery 148: 15-23.
15. Lermite E, Pessaux P, Brehant O, Teyssedou C, Pelletier I, Etienne S, et al. (2007) Risk factors of pancreatic fistula and delayed gastric emptying after pancreaticoduodenectomy with pancreaticogastrostomy. J Am Coll Surg 204: 588-596.
16. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD,. (2004) Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg 8: 951-959.
17. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, et al. (2007) Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg 246: 1058-1064.
18. Rosso E, Casnedi S, Pessaux P, Oussoultzoglou E, Panaro F, Mahfud M, et al. (2009) The role of 'fatty pancreas' and of BMI in the occurrence of pancreatic fistula after pancreaticoduodenectomy. J Gastrointest Surg 13: 1845-1851.
19. Winter JM, Cameron JL, Yeo CJ, Alao B, Lillemoe KD, Campbell KA, et al. (2007) Biochemical markers predict morbidity and mortality after pancreaticoduodenectomy. J Am Coll Surg 204: 1029-1036.
20. Roberts KJ, Storey R, Hodson J, Morris-Stiff G, Smith AM,. (2013) Can pancreatic fistula following resection be predicted by the use of preoperative CT imaging? Pancreatology 13: 423-428.
21. House MG, Fong Y, Arnaoutakis DJ, Sharma R, Winston CB, Protic M, et al. (2008) Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 12: 270-278.
22. Pratt WB, Callery MP, Vollmer CM Jr,. (2008) Risk prediction for development of pancreatic fistula using the ISGPF classification scheme. World J Surg 32: 419-428.
23. Yang YM, Tian XD, Zhuang Y, Wang WM, Wan YL, Huang YT,. (2005) Risk factors of pancreatic leakage after pancreaticoduodenectomy. World J Gastroenterol 11: 2456-2461.
24. Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr,. (2013) A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg 216: 1-14.
25. Yamamoto Y, Sakamoto Y, Nara S, Esaki M, Shimada K, Kosuge T,. (2011) A preoperative predictive scoring system for postoperative pancreatic fistula after pancreaticoduodenectomy. World J Surg 35: 2747-2755.
26. DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, et al. (2006) Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg 244: 931-937.
27. Fuks D, Piessen G, Huet E, Tavernier M, Zerbib P, Michot F, et al. (2009) Life-threatening postoperative pancreatic fistula (grade C) after pancreaticoduodenectomy: incidence, prognosis, and risk factors. Am J Surg 197: 702-709.
28. Kim WS, Choi DW, Choi SH, Heo JS, Kim MJ, Song SC, et al. (2011) Clinical validation of the ISGPF classification and the risk factors of pancreatic fistula formation following duct-to-mucosa pancreaticojejunostomy by one surgeon at a single centre. J Gastrointest Surg 15: 2187-2192.
29. Ogilvie R,. (1933) The islands of the Langerhans in 19 cases of obesity. J Pathol 37: 473-481.
30. Mathur A, Marine M, Lu D, Swartz-Basile DA, Saxena R, Zyromski NJ, et al. (2007) Non-alcoholic fatty pancreas disease. HPB 9: 312-318.
31. Shimoda M, Katoh M, Yukihiro I, Kita J, Sawada T, Kubota K,. (2012) Body mass index is a risk factor of pancreatic fistula after pancreaticoduodenectomy. Am Surg 78: 190-194.
32. Sledzianowski JF, Duffas JP, Muscari F, Suc B, Fourtanier F,. (2005) Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy. Surgery 137: 180-185.
33. Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, et al. (2007) Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188: 1307-1312.
34. Speliotes EK, Massaro JM, Hoffmann U, Foster MC, Sahani DV, Hirschhorn JN, et al. (2008) Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study. J Gastroenterol Hepatol 23: 894-899.
35. Hu HH, Kim HW, Nayak KS, Goran MI,. (2010) Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans. Obesity (Silver Spring) 18: 841-847.
36. Kim Z, Kim MJ, Kim JH, Jin SY, Kim YB, Seo D, et al. (2009) Prediction of postoperative pancreatic fistula in pancreaticoduodenectomy patients using preoperative MRI: a pilot study. HPB 11: 215-221.
37. Lee SE, Jang JY, Lim CS, Kang MJ, Kim SH, Kim MA, et al. (2010) Measurement of pancreatic fat by magnetic resonance imaging: predicting the occurrence of pancreatic fistula after pancreatoduodenectomy. Ann Surg 251: 932-936.
38. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, et al. (2009) Non-invasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94: 4070-4076.
39. Zyromski NJ, Mathur A, Gowda GA, Murphy C, Swartz-Basile DA, Wade TE, et al. (2009) Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology 9: 410-419.
40. Al-Haddad M, Khashab M, Zyromski N, Pungpapong S, Wallace MB, Scolapio J, et al. (2009) Risk factors for hyperechogenic pancreas on endoscopic ultrasound: a case-control study. Pancreas 38: 672-675.
41. Cameron JL, Riall TS, Coleman J, Belcher KA,. (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244: 10-15.
42. Gerritsen A, Besselink MG, Cieslak KP, Vriens MR, Steenhagen E, van Hillegersberg R, et al. (2012) Efficacy and complications of nasojejunal, jejunostomy and parenteral feeding after pancreaticoduodenectomy. J Gastrointest Surg 16: 1144-1151.
43. Wajchenberg BL,. (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697-738.
44. Lee JS, Kim SH, Jun DW, Han JH, Jang EC, Park JY, et al. (2009) Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome. World J Gastroenterol 15: 1869-1875.
45. Smits MM, van Geenen EJ,. (2011) The clinical significance of pancreatic steatosis. Nat Rev Gastroenterol Hepatol 8: 169-177.
46. Tranchart H, Gaujoux S, Rebours V, Vullierme MP, Dokmak S, Levy P, et al. (2012) Preoperative CT scan helps to predict the occurrence of severe pancreatic fistula after pancreaticoduodenectomy. Ann Surg 256: 139-145.